Christopher S. Fraser
Affiliations: | Molecular and Cellular Biology | University of California, Davis, Davis, CA |
Website:
http://biosci3.ucdavis.edu/Faculty/Profile/View/369Google:
"Christopher S. Fraser"Bio:
https://www.mcb.ucdavis.edu/faculty-labs/fraser/Home.html
http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285080
Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Villa N, Fraser CS. (2023) Human eukaryotic initiation factor 4G directly binds the 40S ribosomal subunit to promote efficient translation. Biorxiv : the Preprint Server For Biology |
O'Sullivan MH, Fraser CS. (2023) Monitoring RNA restructuring in a human cell-free extract reveals eIF4A-dependent and eIF4A-independent unwinding activity. The Journal of Biological Chemistry. 104936 |
Lipo E, Asrat S, Huo W, et al. (2022) 5' Untranslated mRNA Regions Allow Bypass of Host Cell Translation Inhibition by Legionella pneumophila. Infection and Immunity. e0017922 |
Izidoro MS, Sokabe M, Villa N, et al. (2022) Human eukaryotic initiation factor 4E (eIF4E) and the nucleotide-bound state of eIF4A regulate eIF4F binding to RNA. The Journal of Biological Chemistry. 102368 |
Lapointe CP, Grosely R, Sokabe M, et al. (2022) eIF5B and eIF1A reorient initiator tRNA to allow ribosomal subunit joining. Nature |
Brito Querido J, Sokabe M, Kraatz S, et al. (2020) Structure of a human 48 translational initiation complex. Science (New York, N.Y.). 369: 1220-1227 |
Cunningham EB, Hajarizadeh B, Amin J, et al. (2020) Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Howard CM, Bearss N, Subramaniyan B, et al. (2019) The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells. Frontiers in Oncology. 9: 284 |
Grebely J, Conway B, Cunningham EB, et al. (2018) Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy. The International Journal On Drug Policy. 62: 94-103 |
Avanzino BC, Jue H, Miller CM, et al. (2018) Molecular mechanism of poliovirus Sabin vaccine strain attenuation. The Journal of Biological Chemistry |